Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioSig Technologies, Inc.

3.68
-0.1300-3.41%
Post-market: 3.700.0200+0.54%19:55 EDT
Volume:554.73K
Turnover:2.08M
Market Cap:115.28M
PE:-4.92
High:3.92
Open:3.87
Low:3.63
Close:3.81
Loading ...

Company Profile

Company Name:
BioSig Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
5
Office Location:
12424 Wilshire Blvd,Suite 745,Los Angeles,California,United States
Zip Code:
90025
Fax:
203 429 5044
Introduction:
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Directors

Name
Position
Henry McPhie
Chief Executive Officer and Director
Morgan Lekstrom
Chairman of the Board
Christopher A. Baer
Independent Director
Donald F. Browne
Independent Director
Steven E. Abelman
Independent Director
Anthony Amato
Director

Shareholders

Name
Position
Henry McPhie
Chief Executive Officer and Director
Ferdinand Groenewald
Interim Chief Financial Officer